These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9385528)

  • 41. [Clinical study of subcutaneous administration of gonadotropin-releasing hormone agonist every six weeks in girls with idiopathic central precocious puberty].
    Liang Y; Wei H; Zhang JL; Hou L; Luo XP
    Zhonghua Er Ke Za Zhi; 2004 Nov; 42(11):845-9. PubMed ID: 15631714
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Final height after long-term treatment with triptorelin slow release for central precocious puberty: importance of statural growth after interruption of treatment. French study group of Decapeptyl in Precocious Puberty.
    Carel JC; Roger M; Ispas S; Tondu F; Lahlou N; Blumberg J; Chaussain JL
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1973-8. PubMed ID: 10372696
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Can the TW3 bone age determination method provide additional criteria for growth hormone treatment in adopted girls with early puberty? A comparison of the Tanner-Whitehouse 3 method with the Greulich-Pyle and the Tanner-Whitehouse 2 methods.
    Proos LA; Lönnerholm T; Jonsson B; Tuvemo T
    Horm Res Paediatr; 2010; 73(1):35-40. PubMed ID: 20190538
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Basal luteinizing hormone/follicle stimulating hormone ratio in diagnosis of central precocious puberty.
    Supornsilchai V; Hiranrat P; Wacharasindhu S; Srivuthana S; Aroonparkmongkol S
    J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S145-51. PubMed ID: 12929982
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Study on cases of precocious puberty].
    Nanbu A; Kumamoto Y; Takagi Y; Maruta H
    Hinyokika Kiyo; 1989 Oct; 35(10):1715-20. PubMed ID: 2532862
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predictive factors for the effect of gonadotrophin releasing hormone analogue therapy on the height of girls with idiopathic central precocious puberty.
    Brauner R; Malandry F; Rappaport R
    Eur J Pediatr; 1992 Oct; 151(10):728-30. PubMed ID: 1425790
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of central precocious puberty: lessons from a 15 years prospective trial. German Decapeptyl Study Group.
    Partsch CJ; Heger S; Sippell WG
    J Pediatr Endocrinol Metab; 2000 Jul; 13 Suppl 1():747-58. PubMed ID: 10969917
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone.
    Pasquino AM; Pucarelli I; Roggini M; Segni M
    J Clin Endocrinol Metab; 2000 Feb; 85(2):619-22. PubMed ID: 10690865
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Height prognosis of children with true precocious puberty and growth hormone deficiency: effect of combination therapy with gonadotropin releasing hormone agonist and growth hormone.
    Cara JF; Kreiter ML; Rosenfield RL
    J Pediatr; 1992 May; 120(5):709-15. PubMed ID: 1533661
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The response to gonadotropin releasing hormone (GnRH) stimulation test does not predict the progression to true precocious puberty in girls with onset of premature thelarche in the first three years of life.
    Bizzarri C; Spadoni GL; Bottaro G; Montanari G; Giannone G; Cappa M; Cianfarani S
    J Clin Endocrinol Metab; 2014 Feb; 99(2):433-9. PubMed ID: 24297793
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Final height after gonadotrophin releasing hormone agonist treatment for central precocious puberty: the Dutch experience.
    Mul D; Oostdijk W; Otten BJ; Rouwé C; Jansen M; Delemarre-van de Waal HA; Waelkens JJ; Drop SL
    J Pediatr Endocrinol Metab; 2000 Jul; 13 Suppl 1():765-72. PubMed ID: 10969919
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Final height outcome after three years of growth hormone and gonadotropin-releasing hormone agonist treatment in short adolescents with relatively early puberty.
    van Gool SA; Kamp GA; Visser-van Balen H; Mul D; Waelkens JJ; Jansen M; Verhoeven-Wind L; Delemarre-van de Waal HA; de Muinck Keizer-Schrama SM; Leusink G; Roos JC; Wit JM
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1402-8. PubMed ID: 17284626
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Growth outcome during GnRH agonist treatments for slowly progressive central precocious puberty.
    Massart F; Federico G; Harrell JC; Saggese G
    Neuroendocrinology; 2009; 90(3):307-14. PubMed ID: 19641297
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Unsustained central sexual precocity in four girls.
    Schwarz HP; Tschaeppeler H; Zuppinger K
    Am J Med Sci; 1990 Apr; 299(4):260-4. PubMed ID: 2108584
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bone age progression during five years of substitutive therapy for the induction of puberty in thalassemic girls--effects on height and sitting height.
    Filosa A; Di Maio S; Lamba M; Baron I; Saviano A; Esposito G
    J Pediatr Endocrinol Metab; 1999; 12(4):525-30. PubMed ID: 10417968
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Idiopathic precocious puberty versus puberty in adopted children; auxological response to gonadotrophin-releasing hormone agonist treatment and final height.
    Kempers MJ; Otten BJ
    Eur J Endocrinol; 2002 Nov; 147(5):609-16. PubMed ID: 12444892
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effect of gonadotropin-releasing hormone analog combined with stanazolol on final height in girls with idiopathic central precocious puberty and apparent decrease of linear growth].
    Li YH; Zhu SY; Ma HM; Su Z; Chen HS; Chen QL; Gu YF; Du ML
    Zhonghua Er Ke Za Zhi; 2013 Nov; 51(11):807-12. PubMed ID: 24484553
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ultrasound assessment of breast development: distinction between premature thelarche and precocious puberty.
    Youn I; Park SH; Lim IS; Kim SJ
    AJR Am J Roentgenol; 2015 Mar; 204(3):620-4. PubMed ID: 25714294
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Clinical study on treatment of female idiopathic precocious puberty with combined therapy of Chinese medicine and megestrol acetate].
    Cai DP; Ji ZY; Shi YM
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2001 Oct; 21(10):732-5. PubMed ID: 12575602
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Disorders of Puberty: An Approach to Diagnosis and Management.
    Klein DA; Emerick JE; Sylvester JE; Vogt KS
    Am Fam Physician; 2017 Nov; 96(9):590-599. PubMed ID: 29094880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.